TABLE 2.
Study Cohorts | Hannover Cohort | DEFINE Cohort | Liverpool Cohort |
---|---|---|---|
Number of NA‐treated patients (n) | 45 | 50 | 53 |
Number of retested plasma samples (n) | 191 | 346 † | 26 |
Evaluated HBV assays | |||
Without RT | cobas HBV (cobas HPS*) | cobas HBV (cobas HPS*) | cobas HBV |
Xpert HBV | |||
With RT | cobas HBV+RT | cobas HBV+RT | Aptima HBV (TMA) |
Aptima HBV (TMA) | |||
Specific value for the study | Longitudinal follow‐up available | Longitudinal follow‐up available | Direct HBV‐RNA quantification performed |
Original test that was used before the study.
A total of 271 samples with enough remaining volume generated valid results for HBV DNA for both cobas HBV and Aptima HBV.